Opens.
Delivers.
Maintains.
- May 2013:Why Intersect ENT is an Example of Hope for the Medtech Industry
- Mar 2013:Sinus “Stent” Helps Patients Breathe Easier
- Jan 2013:Warren Man With Chronic Sinusitus Breathes Easy After Implant Surgery
- Jan 2013:Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients
- May 2013:Why Intersect ENT is an Example of Hope for the Medtech Industry
- Mar 2013:Sinus “Stent” Helps Patients Breathe Easier
- Jan 2013:Warren Man With Chronic Sinusitus Breathes Easy After Implant Surgery
- Jan 2013:Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients
Newsroom
Newsroom
Press Releases
To read current and historical press releases issued by Intersect ENT, Inc., click here
In The News
For links to news and articles related to Intersect ENT, Inc. and the PROPEL steroid-releasing implant, click here
Events & Awards
For dates and locations of upcoming events where you can learn more about PROPEL, and awards won for PROPEL research, click here
see propel in action
Watch a brief video to see how PROPEL opens, delivers, and maintains.
patient story
A chronic sinusitis patient recently featured on NBC news.
Publications
Kennedy DW.
The PROPEL steroid releasing bioabsorbable implant to improve outcomes of sinus surgery.
Expert Review of Respiratory Medicine. 2012; 6(5):493-498.
Han JK, Marple BF, Smith TL et al.
Effect of steroid-releasing sinus implants on post-operative medical and surgical interventions.
Int Forum Allergy Rhinol. 2012; 2:271-279.